Fund Holdings — DAFNA Capital Management LLC

Total Portfolio Value:
$352.66M
Total Bought:
$33.40M
Total Sold:
$14.90M
Net Transaction:
+$18.50M
Notable People:
Nathan Fischel, Fariba Fischel Ghodsian, Dafna Holdings, L.P.
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Spdr S&p Biotech EtfETF
ST STR SP BIOT
397,505404,505+7,000$35.80M$32.81M9.30%-$2.99M
Stereotaxis, Inc.(STXS)13,680,55413,680,5540$31.19M$24.08M6.83%-$7.11M
Revolution Medicines, Inc.(RVMD)631,176656,176+25,000$27.61M$23.20M6.58%-$4.41M
Merus N V451,804461,804+10,000$19.00M$19.44M5.51%+$439.0K
AtriCure, Inc.(ATRC)641,673592,273-49,400$19.61M$19.11M5.42%-$502.8K
Cytokinetics, Incorporated(CYTK)398,100398,1000$18.73M$16.00M4.54%-$2.73M
Blueprint Medicines Corp149,763152,263+2,500$13.06M$13.48M3.82%+$414.5K
Ishares Nasdaq Biotech IndxETF102,500102,5000$13.55M$13.11M3.72%-$441.8K
Axogen, Inc.(AXGN)846,882680,782-166,100$13.96M$12.59M3.57%-$1.36M
Ascendis Pharma A/SADR(ASND)103,35580,398-22,957$14.23M$12.53M3.55%-$1.70M
IDEAYA Biosciences, Inc.(IDYA)498,827589,330+90,503$12.82M$9.65M2.74%-$3.17M
Xenon Pharmaceuticals Inc.(XENE)273,739273,7390$10.73M$9.18M2.60%-$1.55M
Kalvista Pharmaceuticals Inc811,678752,359-59,319$6.87M$8.68M2.46%+$1.81M
Neurocrine Biosciences, Inc.(NBIX)71,61571,6150$9.78M$7.92M2.25%-$1.85M
Syndax Pharmaceuticals, Inc.(SNDX)542,002544,502+2,500$7.17M$6.69M1.90%-$476.1K
Day One Biopharmaceuticals I
COM
731,363731,3630$9.27M$5.80M1.64%-$3.47M
Tandem Diabetes Care, Inc.(TNDM)223,208294,208+71,000$8.04M$5.64M1.60%-$2.40M
UroGen Pharma Ltd.(URGN)492,515492,5150$5.25M$5.45M1.54%+$201.9K
Biohaven Ltd.(BHVN)220,235220,2350$8.23M$5.29M1.50%-$2.93M
Mineralys Therapeutics, Inc.(MLYS)146,500309,200+162,700$1.80M$4.91M1.39%+$3.11M
Arcus Biosciences, Inc.(RCUS)254,217625,126+370,909$3.79M$4.91M1.39%+$1.12M
Ascendis Pharma A/SNOTE 2 250 4 0(ASND)000$4.41M$4.71M1.34%+$297.5K
DexCom, Inc.(DXCM)65,55265,5520$5.10M$4.48M1.27%-$621.4K
BioCryst Pharmaceuticals, Inc.(BCRX)667,000558,255-108,745$5.02M$4.19M1.19%-$828.9K
Edgewise Therapeutics, Inc.(EWTX)187,140183,140-4,000$5.00M$4.03M1.14%-$967.6K
Lakefront Biotherapeutics NVADR(LKFT)130,175130,1750$3.58M$3.27M0.93%-$309.8K
Inogen, Inc.(INGN)208,790458,065+249,275$1.91M$3.27M0.93%+$1.35M
Insulet Corporation(PODD)12,40011,900-500$3.24M$3.13M0.89%-$112.2K
Alkermes plcSHS(ALKS)120,70094,200-26,500$3.47M$3.11M0.88%-$360.8K
Kura Oncology, Inc.(KURA)448,368463,368+15,000$3.91M$3.06M0.87%-$847.1K
Stoke Therapeutics, Inc.(STOK)171,097443,998+272,901$1.89M$2.95M0.84%+$1.07M
Immunovant, Inc.(IMVT)107,996169,996+62,000$2.68M$2.91M0.82%+$230.2K
Bicara Therapeutics Inc105,500212,001+106,501$1.84M$2.76M0.78%+$924.6K
Accuray Inc1,222,3581,222,3580$2.42M$2.19M0.62%-$232.2K
2seventy Bio Inc429,252429,2520$1.26M$2.12M0.60%+$858.5K
Proqr Therapeutics N VSHS EURO
SHS EURO
1,567,5611,567,5610$4.15M$2.08M0.59%-$2.07M
COMPASS Pathways plcADS(CMPS)243,210711,046+467,836$919.3K$2.03M0.58%+$1.11M
Allogene Therapeutics Inc1,240,1181,380,118+140,000$2.64M$2.01M0.57%-$626.5K
TELA Bio, Inc.(TELA)1,441,0291,441,0290$4.35M$1.76M0.50%-$2.59M
Align Technology Inc5,50011,000+5,500$1.15M$1.75M0.50%+$600.7K
Denali Therapeutics Inc.(DNLI)0127,900+127,900$0$1.74M0.49%+$1.74M
Astria Therapeutics Inc299,775314,775+15,000$2.68M$1.68M0.48%-$999.1K
Viking Therapeutics, Inc.(VKTX)64,51664,5160$2.60M$1.56M0.44%-$1.04M
Regulus Therapeutics Inc875,200847,176-28,024$1.38M$1.48M0.42%+$99.7K
BrainsWay Ltd.ADS(BWAY)193,208156,533-36,675$1.82M$1.48M0.42%-$339.6K
ORIC Pharmaceuticals, Inc.(ORIC)0242,000+242,000$0$1.35M0.38%+$1.35M
Keros Therapeutics, Inc.(KROS)130,316130,3160$2.06M$1.33M0.38%-$735.0K
Lexeo Therapeutics, Inc.(LXEO)393,083378,083-15,000$2.59M$1.31M0.37%-$1.27M
Iteos Therapeutics Inc188,347213,347+25,000$1.45M$1.27M0.36%-$172.8K
Palvella Therapeutics, Inc.(PVLA)71,45243,348-28,104$857.4K$1.21M0.34%+$355.9K
ARS Pharmaceuticals, Inc.(SPRY)88,79095,290+6,500$936.7K$1.20M0.34%+$262.0K
Lineage Cell Therapeutics, Inc.(LCTX)2,511,3742,511,3740$1.26M$1.13M0.32%-$127.8K
Alector Inc912,928912,9280$1.73M$1.12M0.32%-$602.5K
Foghorn Therapeutics Inc.(FHTX)186,717304,752+118,035$881.3K$1.11M0.32%+$231.0K
Immatics N.V.SHS(IMTX)245,000245,0000$1.74M$1.10M0.31%-$637.0K
Structure Therapeutics IncADS35,50059,000+23,500$962.8K$1.02M0.29%+$58.5K
Yarrow Bioscience Inc(YARW)0636,103+636,103$0$1.01M0.28%+$1.01M
MediWound Ltd.SHS NEW(MDWD)64,47964,4790$1.15M$1.00M0.28%-$147.0K
Gossamer Bio, Inc.(GOSS)1,409,262907,854-501,408$1.27M$998.6K0.28%-$276.2K
BioNTech SEADS(BNTX)8,50010,500+2,000$968.6K$956.1K0.27%-$12.4K
Autolus Therapeutics plcADS(AUTL)586,667586,6670$1.38M$909.3K0.26%-$469.3K
Sage Therapeutics Inc108,200108,2000$587.5K$860.2K0.24%+$272.7K
Korro Bio, Inc.(KRRO)047,086+47,086$0$819.8K0.23%+$819.8K
Century Therapeutics, Inc.(IPSC)1,704,2321,704,2320$1.72M$811.2K0.23%-$910.1K
Larimar Therapeutics, Inc.(LRMR)371,434371,4340$1.44M$798.6K0.23%-$638.9K
PolyPid Ltd.(PYPD)291,273291,2730$885.5K$789.4K0.22%-$96.1K
Taysha Gene Therapies, Inc.(TSHA)522,500522,5000$903.9K$726.3K0.21%-$177.7K
Bicycle Therapeutics PlcADS120,79980,799-40,000$1.69M$686.0K0.19%-$1.01M
Neurogene Inc.(NGNE)51,50051,5000$1.18M$603.1K0.17%-$574.2K
Cardiff Oncology, Inc.(CRDF)0150,000+150,000$0$471.0K0.13%+$471.0K
Erasca, Inc.(ERAS)0340,000+340,000$0$465.8K0.13%+$465.8K
InflaRx N.V.(IFRX)0450,000+450,000$0$459.0K0.13%+$459.0K
Adicet Bio Inc600,000600,0000$577.2K$453.0K0.13%-$124.2K
Aquestive Therapeutics Inc127,000142,000+15,000$452.1K$411.8K0.12%-$40.3K
Compugen Ltd.(CGEN)447,202272,402-174,800$684.2K$397.7K0.11%-$286.5K
ADC Therapeutics SASHS(ADCT)224,081224,0810$445.9K$316.0K0.09%-$130.0K
Sutro Biopharma, Inc.(STRO)437,079437,0790$804.2K$284.4K0.08%-$519.9K
Aprea Therapeutics, Inc.(APRE)137,174137,1740$451.3K$279.8K0.08%-$171.5K
Tessera Defense and Homeland Security Inc.(HLSQ)401,136401,1360$292.9K$222.9K0.06%-$70.0K
Nevro Corp38,00038,0000$141.4K$221.9K0.06%+$80.6K
Black Diamond Therapeutics I140,000140,0000$299.6K$217.0K0.06%-$82.6K
Spero Therapeutics, Inc.(SPRO)125,000125,0000$128.8K$90.0K0.03%-$38.8K
Tenaya Therapeutics, Inc.(TNYA)047,319+47,319$0$27.0K0.01%+$27.0K
Acelyrin Inc87,9890-87,989$276.3K$0—-$276.3K
Acrivon Therapeutics Inc112,4140-112,414$676.7K$0—-$676.7K
Centessa Pharmaceuticals PlcADS47,4530-47,453$794.8K$0—-$794.8K
Compass Therapeutics, Inc.(CMPX)158,3940-158,394$229.7K$0—-$229.7K
Masimo Corp3,0000-3,000$495.9K$0—-$495.9K
Perspective Therapeutics, Inc.(CATX)130,1690-130,169$415.2K$0—-$415.2K
Vir Biotechnology, Inc.(VIR)100,0000-100,000$734.0K$0—-$734.0K
Page 1 of 1
DAFNA Capital Management LLC — 13F Holdings — Q1 2025 | TickerTrail